General anaesthesia potentiates both the respiratory and circulatory effects of opiates and their derivatives. Used intravenously in doses which would have little effect in conscious patients, these drugs can produce marked depression during general anaesthesia. A previous paper has described the respiratory effects of pentazocine and compared them with those of pethidine under halothane-oxygen anaesthesia (Davie, Scott and Stephen, 1970) . It was thought wise to carry out a similar comparison of the effects of these drugs on the central haemodynamics.
METHOD
Thirteen female patients were studied aged I9-60 years. All were about to undergo minor gynaecological surgery and all gave permission for the investigation.
Anaesthesia was induced with thiopentone 500 mg i.v. 1 hour after premedication with atropine 0.6 mg ijn. Anaesthesia was maintained using nitrous oxide and oxygen (3:1 L/min in a semiclosed system with carbon dioxide absorption) to which halothane 1 per cent was added. A central venous catheter was passed percutaneously through a cubital fossa vein using the Seldinger technique.
Cardiac output was measured using the indocyanine green dye dilution method with a Waters XE302 earpiece and densitometer. The difficulties of cardiac output estimation using an earpiece are appreciated, especially in regard to calibration and presentation of the output in absolute terms.
However, when the ear is well vasodilated and posture is not altered, the method can show sequential changes in the same patient. This is borne out by the present investigation where the changes, though not large, were very consistent from patient to patient. Electrocardiography was continuous and the heart rate displayed by a Sanborn cardiotachometer 350-3400A. Arterial blood pressure was measured by standard sphygmomanometry, the mean pressure being calculated as the diastolic pressure plus one-third of the pulse pressure. Central venous pressure was measured with a Sanborn 267 AC pressure transducer, the zero reference point being taken as 5 cm below the manubrium sterni. All electrical measurements were recorded simultaneously on a Sanborn 7700 6-channel recorder.
Four recordings of cardiac output were made at 2-minute intervals in the control period, following which either pentazocine 30 mg or pethidine 30 mg was given intravenously over 30 seconds. ;Although equal doses of each drug were used it should be emphasized that pentazocine is 2-2^ times more potent as an analgesic than pethidine.) Cardiac output was again recorded at 2-minute intervals. Ten minutes after the first injection, the same drug and dosage was repeated, all measurements continuing for a further 10 minutes. Thus each patient had twelve estimations of cardiac output, four in the control period, four after the first injection and four after the second. Seven patients received pentazocine and six patients pethidine. Ventilation, which was spontaneous in all cases, was measured with a Wright respirometer. Blood gases were checked in each of the three phases of the experiment, capillary blood being used for the measurement of pH and Pa^o,. These samples were immediately placed on ice and the estimations were performed within 15 minutes. Pa C o = was interpolated from the Astrup nomogram.
RESULTS
Following intravenous pentazocine the cardiac output fell briefly by 20 per cent ( fig. 1 ; table I), recovering almost to the control level after 10 minutes. A similar, but less marked, effect followed the second injection. The reduction in output after the injection was statistically significant (P<0.01) but after the second injection it was not. Pethidine produced almost the same pattern of change ( fig. 2 ; table II), the mean reduction being rather less, probably due to the fact that one of the six cases had a rise in output while the remaining five had a fall in output.
Heart rate. This did not change significantly after either drug; thus output changes were in terms of stroke volume (figs. 1 and 2).
Mean arterial pressure. A small rise in mean arterial pressure occurred slowly in both groups of patients during the period of observation after the first injection ( figs. 1 and 2) .
Central venous pressure. Both pentazocine and psthidine caused a sharp rise in central venous pressure, this being more marked after pentazocine ( figs. 1 and 2 ). The response of the c.v.p. was rapid ( fig. 3) , and the high pressure was maintained after recovery of the cardiac output to control levels. The rise in c.v.p. was statistically significant (P<0.02) in both groups of patients.
Respiration. The minute volume and respiratory rate changed in the same way after each drug as described in a previous paper (Davie, Scott and Stephen, 1970) .
Blood gases. These also changed as expected with the respiratory depression caused by each drug. Pa^oo rose on average by 9 mm Hg in the pentazocine group and by 16 mm Hg in the pethidine group. 
DISCUSSION
The most notable features of this study were the falls in cardiac output immediately following intravenous injection of both drugs and the marked and sustained rise in central venous pressure. The decreases in cardiac output were only small and transient and probably of little clinical significance. That tie central venous pressure rose simultaneously with the fall in output would indicate a direct myocardial effect, but one would expect the venous pressure to fall after cardiac output had returned to normal. The apparent simplicity of the experimental protocol, i.e. measurements made before and after injection of each drug, is deceptive. In fact, a complex situation arises once respiratory depression occurs. Apart from the direct effects of the drug upon the myocardium and the peripheral circulation, the rising carbon dioxide tension will have effects of its own, tending to raise both cardiac output and arterial blood pressure (Theye, Milde and Michenfelder, 1966; Prys-Roberts et al., 1967) . Moreover, as less halothane is being inhaled, the effects of this drug cannot be assumed to be stable throughout the observation period.
It is difficult, therefore, on the data available, to explain in physiological terms the sustained rise in central venous pressure. Studying conscious patients suffering from coronary thrombosis, Rees and associates (1967) showed that neither pethidine nor heroin had any marked effect upon central venous pressure. It is possible, therefore, that the effect is closely associated with the concurrent general anaesthesia. Whether it is specifically associated with halothane anaesthesia it is not possible to say. Prys-Roberts and associates (1967) found that hypercarbia was associated with a raised central venous pressure during nitrous oxide anaesthesia, but the rise in their cases was not as great as in this study.
The factors which can affect central venous pressure are varied and numerous. The sustained rise in central venous pressure seen after pentazocine and pethidine administration might be due to an augmentation of the venous return, resulting from an increase in venous tone, though we have no evidence that this occurs. A depressed myccardium requires a higher venous filling pressure to produce the same cardiac output as a normal myocardium. This is said to occur with anaesthetic agents such as halothane which do not increase the release of catecholamines (Theye, 1965) .
The interpretation of central venous pressure during anaesthesia is obviously far from simple and it would appear that it can be quite unrelated to flow. Similar observations have been made under different circumstances (Stephen, Lees and Scott, 1969 
